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correlation between pyrene collected on fil-
ter and pyrene collected on XAD (4. On
average, we found 1.6 pg/m3pyrene on filter
and 1.9 pg/m3 on XAD; i.e., 46% on filter
and 54% on XAD. This is in good agree-
ment with Ny et al. (3). The correlation
between pyrene on filter and the sum of
pyrene on filter and pyrene on XAD was
0.69. Since this is less than 1, it is likely that
a better correlation between pyrene in air
and urinary 1-hydroxypyrene would have
been the result ofusing an XAD backup in
ourstudy.
The timing of urinary sampling is an
important issue. However, it is impossible to
select a perfect sampling time for biological
monitoring. Even ifyou sample for 8 hr and
start at a time point equal to the half-life of
1-hydroxypyrene after the start ofwork,
some of the collected urine will contain 1-
hydroxypyrene from the previous day's
exposure, and day-to-day variation may be
significant. Jongeneelen (4) has studied sam-
ples collected after and before shift and
found a correlation between pyrene in the
air and urinary 1-hydroxypyrene both when
collected after shift and before the shift the
next day. The American Conference of
Industrial Hygienists (ACGIH) has estab-
lished biological exposure indices (BEI) for
several organic compounds (but not pyrene)
and suggested sampling times. The ACGIH
suggested end ofshift and prior to next shift
as the time when sampling time is critical
(5). Compromises have to be made in prac-
tical biomonitoring, but for validation of
methods, 24-hr sampling of urine may be
important.
We agree that 1-hydroxypyrene is the
main metabolite and that other metabolites
are important, but urinary 1-hydroxypyrene
is a marker for PAH exposure and does not
represent the total exposure. A large propor-
tion of PAHs are excreted in feces. In a
recent study ofvoluntary ingestion and der-
mal application of pyrene, less than 4.5%
(ingestion) and 0.2% (dermal) ofthe dose
was recovered in a 48-hr collection period
(6). The study of the influence of genetic
factors and lifestyle factors is important in
validating biomarkers like urinary 1-
hydroxypyrene. We arecurrentlyconducting
such studies. But PAH uptake is also influ-
enced by particle size ofthe PAH. The new
filtercassettes called IOM (7) showthat con-
struction of cassette orifice can have a great
impact on the fraction samples and may be
more important than AD backup,which
mostly gives a constant loss that can be cor-
rectedfor.
There is still need for more validation
studies of the biomarker 1-hydroxypyrene.
To sum up, we would like tO cite from
implementation of the BET (5i): "Biological
monitoring should be considered comple-
mentary to air monitoring. Itshould be con-
ducted when it offers an advantage over the
useofairmonitoringalone."
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Radiation andChildhood Cancer
Ostensibly, the impetus for Wakeford's
review ofreported associations ofchildhood
cancers with radiation exposures (EHP
103:1018-1025) was to refuteourjudgment
that cancer risk coefficients for low-dose
exposures ofpopulations, as officially adopt-
ed by national and international radiation
commissions, have been substantially under-
estimated (EHP 102:656-667). We based
our judgment on documented inconsisten-
cies and omissions in theliterature, aswell as
on discrepancies between official predictions
and observed health effects among various
groups, induding nudear workers and resi-
dents of radioactively contaminated areas.
We reviewed a wide range ofstudies under
low-dose exposure conditions, especially
those that found radiogenic cancer risk coef-
ficients inconsistent with official estimates
forprotractedlow-dose exposures. Thesesig-
nificant discrepancies between observed and
expected values contradict the model
assumptions made when low-dose, low-rate
risks were extrapolated from primarily one-
flash, high-dose effects (1,2.
Wakeford ignores these inconsistencies
by neither refuting nor discussing them. His
substantive criticism ofour contribution is
limited to just two ofour reported finding,
which we can accept. Yet, this in no way
affects ourstated condusions:
1) We had overlooked a downward revi-
sion ofthe prenatal exposure risk of20 fatal
childhood cancers per 104 person-cGy (3) to
12.7 cancer deaths (and 17 nonfatal cancers)
per 104 person-cGy, as derived from the
Oxford Survey of Childhood Cancers
(OSCC) (4), generally recognized as the
most extensive database on childhood can-
cers. The main body ofWakeford's paper,
however, is apresentation ofalternative radi-
ogenic riskestimates, emphasizing those that
are closer to the generally accepted norm;
i.e., those derived from theA-bomb survivor
data. This brief communication is not the
appropriate place for adetailed evaluation of
Wakeford's selection ofdata. Yet, a crucial
omission from his review is the evidence we
referenced in our paper showing that, as a
consequence ofsignificant selection effects
among A-bomb survivors, prenatal exposure
risks as derived from A-bomb data are
intrinsically incompatible with those based
on X-ray exposures ofgeneral populations
(such as the OSCC). Recently released data
on early radiation injuries among the LSS
survivor cohort by the Radiation Effects
Research Foundation, Hiroshima, strongly
confirm Stewart's earlier condusions about
the effects ofselection (5). From now on,
evaluations of risk from prenatal exposures
to X-rays, low-dose gamma rays, or internal
radioisotopes will have to stand on their own
reliability in methodology, since agreement
or disagreement with the A-bomb data
appears tohavebecomeirrelevant.
2) Regarding the "Gardner hypothesis"
(postulating a genetic component for
leukemia in young people through precon-
ceptual parental exposure), we reviewed sev-
eral findings, supportive and unsupportive.
In view of the unknown contribution of
internal radioisotopes to the health hazards
in some ofthe conflictingfindings, aswell as
confounding dustering effects of leukemia
with infectious epidemics in rural areas (6),
we consider the discussion as undecided at
this time. In contrast to this more cautious
approach, Wakeford, without presenting a
plausible counter-hypothesis for either the
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Sellafield or some other reported leukemia
dusters, leaves little room for doubt by con-
duding that "a causal interpretation of the
association between childhood leukemia and
paternal preconceptional irradiation reported
byGardner et al. cannot besustained."
Taken as a whole, while contributing to
the ongoing discussion on intrauterine and
preconceptional exposure risks for childhood
cancers, Wakeford's paper in no way invali-
dates the major condusions from our review
ofthe literature on health hazards from low-
dose exposures.
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Response
In their wide-ranging, critical review of the
current estimates of the risks of adverse
health effects after exposure to low doses of
ionizing radiation (EHP 102:656-667),
Nussbaum and Kohnlein claim that "offi-
cial" risk estimates derived by scientific bod-
ies such as the Committee on the Biological
Effects of Ionizing Radiation (BEIR V) (1)
"substantially" underestimate true risks. Two
pieces of evidence used by Nussbaum and
Kohnlein in support ofthis contention con-
cern the risk ofchildhood cancer after expo-
sure in utero and the risk of childhood
leukemia after paternal exposure before con-
ception. The stated purpose of my article
(EHP 103:1018-1025) was to provide a
timely review ofthe scientific literature asso-
ciated with these risks and, from this, to
determine how well the pertinent criticism
of Nussbaum and Kohnlein stood up to
close scrutiny.
Nussbaum and Kohnlein persist in refer-
ring to a single high point estimate of the
risk of childhood cancer after intrauterine
irradiation, using the database ofthe Oxford
Survey of Childhood Cancers (OSCC). I
noted in my article that this excess absolute
risk coefficient for cancer incidence (not
mortality) under 15 years of age of 13.6%
(95% CI, 10.0-18.4%) per Gy had been
derived by Muirhead and Kneale (2 using
OSCC data. However, the fetal doses upon
which this estimate was based were aperson-
al communication from G.M. Ardran to
Stewart and Kneale (3), which "may need to
be revised in the light of further evidence."
Stewart and Kneale later stated that "the
accuracy of the Ardran estimates . . . is an
unknown quantity, though we have since
learnt that another expert in the subject
would have given us a different estimate of
the time trend" (4). Muirhead and Kneale
(2) also derived an equivalent risk coefficient
of6.4% (95% CI, 4.1-10.0%) per Gyfrom
the OSCC data, but based on the fetal dose
estimates ofthe 1972 report of the United
Nations Scientific Committee on the Effects
of Atomic Radiation (UNSCEAR) (5).
However, the accuracy of these dose esti-
mates is also undear (6), although they are
more compatiblewith thetemporal variation
of excess risk displayed by the OSCC data
(7). Given the systematic and statistical
uncertainties inherent in these risk estimates,
it is questionable whether an inconsistency
with the risk experienced by the Japanese
atomic bomb survivors irradiated in utero
can be claimed with any confidence, recog-
nizing the uncertainties also associated with
the riskestimate of0.5% (95% CI, -0.2% to
2.4%) per Gy derived directly from this
group. In any case, the estimate for the
excess riskofcancermortality under 10 years
ofage of2.0-2.5% per Gy presented in the
BEIRVreport (1) is based on OSCC data.
As discussed in my article, the novel
association between the dose of radiation
measured by film badges worn by men
employed at the Sellafield nuclear facility
before the conception of their children and
leukemia in these children has been found to
be confined to those born in Seascale (this is
so, even though more than 90% ofthe chil-
dren ofSellafield workers were born outside
this village). The Seascale association has not
been confirmed byother studies usingobjec-
tive estimates of radiation dose.
Interestingly, Kneale and Stewart, using
OSCC data, concluded that "there is no
support for the idea that exposure of
parental gonads to diagnostic x-rays is con-
ducive to cancer in the next generation" (8).
Further, as pointed out in my article, the
Seascale association cannot be explained by
paternal doses received from internally
deposited radionuclides, and studies ofother
groups associated with such doses have
found no association. It was Sir Richard
Doll and his colleagues who concluded, in a
comprehensive review, that "the hypothesis
that irradiation of the testes causes any
detectable risk of leukaemia in subsequent
offspring cannotbesustained" (9).
Through a detailed review of the scien-
tific literature concerning the risks ofchild-
hood cancer after intrauterine and precon-
ceptional irradiation, I have demonstrated
that the analysis ofNussbaum and Kohnlein
regarding these particular risks does not
withstand examination. Others will have to
decide whether their remaining criticisms
havescientificvalidity.
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